Drugs to reverse Alzheimer's disease prove elusive
Friday, July 25, 2008 - 19:21
in Health & Medicine
Recent clinical trials aimed at halting Alzheimer's have faltered and such treatment appears to be far off. Even so, much has been uncovered about the devastating disease. On Tuesday, someone from the biotech company Myriad Genetics Inc. will stand before hundreds of sober-faced scientists in a conference room in Chicago and try to explain why yet another highly anticipated medication for Alzheimer's disease will not make it to the marketplace.
Read the whole article on LA Times - Health
More from LA Times - Health
Related
- Results from trials of DHA in Alzheimer's disease and age-related cognitive declineSun, 12 Jul 2009, 2:35:51 EDT
- Study bolsters link to maternal Alzheimer's diseaseWed, 30 Jul 2008, 16:15:50 EDT
- Mayo Clinic study continues to refine most effective methods to predict Alzheimer's diseaseTue, 14 Jul 2009, 9:23:04 EDT
- Mount Sinai researchers find new Alzheimer's disease treatment promisingSun, 12 Jul 2009, 7:28:36 EDT
- Novel treatments and current clinical trials for Alzheimer's disease therapies show promiseThu, 23 Oct 2008, 12:09:09 EDT